Brentuximab Vedotin for Systemic Sclerosis

NCT03222492 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Diffuse Cutaneous Systemic Sclerosis
Scleroderma
dcSSc

Interventions

BIOLOGICAL: Brentuximab Vedotin
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]